Literature DB >> 6224677

Potential usefulness of norfloxacin in the treatment of urinary tract infections.

S R Norrby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224677     DOI: 10.1007/bf02029522

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  11 in total

1.  In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.

Authors:  P M Shah; M Ottrad; W Stille
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

2.  Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage.

Authors:  M Eandi; I Viano; F Di Nola; L Leone; E Genazzani
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

3.  Comparative in vitro activity of norfloxacin against urinary tract pathogens.

Authors:  D Haase; B Urias; G Harding; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

4.  Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo.

Authors:  M Rylander; S R Norrby
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

5.  Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.

Authors:  H Giamarellou; J Tsagarakis; G Petrikkos; G K Daikos
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

6.  Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.

Authors:  J G Guerra; E Falconi; J C Palomino; L Benavente; E Antunez de Mayolo
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

7.  In vitro antibacterial activity of norfloxacin (MK-0366).

Authors:  A King; C Warren; K Shannon; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

8.  Antibacterial activity of norfloxacin.

Authors:  S R Norrby; M Jonsson
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

10.  Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections.

Authors:  K Hirai; A Ito; Y Abe; S Suzue; T Irikura; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

View more
  3 in total

1.  [Gyrase inhibitor].

Authors:  W Forth
Journal:  Klin Wochenschr       Date:  1985-10-01

2.  Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice.

Authors:  N Klesel; M Limbert; G Seibert; I Winkler; E Schrinner
Journal:  Infection       Date:  1986       Impact factor: 3.553

3.  Concentrations of norfloxacin in prostatic tissues following oral administration in patients with benign prostatic hyperplasia.

Authors:  N R Netto; P C Palma; G B Srulzon; P L Cortado; R C Fonseca
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.